| 1 | A Novel Niosomal Gel for Topical Delivery of Miltefosine Against Trichophyton indotineae Dermatophytosis in Animal Model | 2.1 | 5 | Citations (PDF) |
| 2 | Deciphering Fluconazole Resistance in Candida auris clade V: The Role of Efflux Pump Gene Expression and Ergosterol Pathway Mutations | 2.2 | 6 | Citations (PDF) |
| 3 | Antifungal Efficacy of Luliconazole-Loaded Nanostructured Lipid-Carrier Gel in an Animal Model of Dermatophytosis | 2.4 | 7 | Citations (PDF) |
| 4 | Pathogenicity Evaluation on Fluconazole-Resistant Candida auris Clade V in Murine Model | 2.2 | 1 | Citations (PDF) |
| 5 | Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018–2023) | 1.7 | 2 | Citations (PDF) |
| 6 | Insights into Persian Gulf Beach Sand Mycobiomes: Promises and Challenges in Fungal Diversity | 2.4 | 3 | Citations (PDF) |
| 7 | Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment | 2.1 | 8 | Citations (PDF) |
| 8 | A comprehensive review on the role of T cell subsets and CAR-T cell therapy in Aspergillus fumigatus infection | 0.5 | 9 | Citations (PDF) |
| 9 | Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I | 2.4 | 4 | Citations (PDF) |
| 10 | High Prevalence of Azole‐Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned? | 2.1 | 5 | Citations (PDF) |
| 11 | In vitro activity of nanoliposomal amphotericin B against terbinafine-resistant Trichophyton indotineae isolates | 1.5 | 3 | Citations (PDF) |
| 12 | Clinical characteristics and outcomes of colonization and infection by yeast species in solid organ transplant recipients: Molecular identification and antifungal susceptibility patterns of isolates | 1.9 | 3 | Citations (PDF) |
| 13 | Five‐year surveillance study of clinical and environmental Triazole‐ResistantAspergillus fumigatus isolates in Iran | 2.1 | 19 | Citations (PDF) |
| 14 | In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs | 2.1 | 6 | Citations (PDF) |
| 15 | Design, synthesis and biological activity of hybrid antifungals derived from fluconazole and mebendazole | 4.5 | 24 | Citations (PDF) |
| 16 | Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae | 2.1 | 14 | Citations (PDF) |
| 17 | Antifungal therapy of Candida biofilms: Past, present and future | 3.7 | 45 | Citations (PDF) |
| 18 | Catheter-associated blood stream infections due to Candida pararugosa in a patient with acute myeloid leukemia: A case report | 1.2 | 6 | Citations (PDF) |
| 19 | In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris | 1.9 | 10 | Citations (PDF) |
| 20 | In-vivo efficiency of the novel azole compounds (ATTAF-1 and ATTAF-2) against systemic candidiasis in a murine model | 1.5 | 3 | Citations (PDF) |
| 21 | An Autochthonous Susceptible Candida auris Clade I Otomycosis Case in Iran | 2.4 | 6 | Citations (PDF) |
| 22 | South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature | 2.1 | 36 | Citations (PDF) |
| 23 | Evaluating a semi‐nested PCR to support histopathology reports of fungal rhinosinusitis in formalin‐fixed paraffin‐embedded tissue samples | 1.4 | 10 | Citations (PDF) |
| 24 | Species Distribution and Antifungal Susceptibilities of
Aspergillus
Section
Fumigati
Isolates in Clinical Samples from the United States | 2.5 | 35 | Citations (PDF) |
| 25 | Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole | 2.1 | 20 | Citations (PDF) |
| 26 | Global prevalence and subgroup analyses of coronavirus disease (COVID‐19) associated Candida auris infections (CACa): A systematic review and meta‐analysis | 2.1 | 61 | Citations (PDF) |
| 27 | In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates | 2.1 | 6 | Citations (PDF) |
| 28 | In Vitro Antifungal Susceptibility Profile of Miltefosine against a Collection of Azole and Echinocandins Resistant Fusarium Strains | 2.4 | 15 | Citations (PDF) |
| 29 | Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species | 1.5 | 53 | Citations (PDF) |
| 30 | Molecular Detection of Azole-Resistant Aspergillus fumigatus Isolates Carrying TR34/L98H Mutations in Soil Samples from the Critical Hospitals | 0.1 | 3 | Citations (PDF) |
| 31 | P026 Antifungal activity of a novel triazole and comparators against a large collection of identified Aspergillus isolates | 1.9 | 0 | Citations (PDF) |
| 32 | P398 COVID-19-associated pulmonary aspergillosis: Species distribution and susceptibility profiles | 1.9 | 0 | Citations (PDF) |
| 33 | Confirmation of fifth
Candida auris
clade by whole genome sequencing | 4.0 | 157 | Citations (PDF) |
| 34 | P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis | 1.9 | 0 | Citations (PDF) |
| 35 | S10.3d Yeast Microbiome in patients with inflammatory bowel disease (IBD) | 1.9 | 0 | Citations (PDF) |
| 36 | P244 Catheter-associated blood stream infections due to Wickerhamiella pararugosa in a patient with acute myeloid leukemia: Review of lit eratures | 1.9 | 0 | Citations (PDF) |
| 37 | A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles | 0.6 | 3 | Citations (PDF) |
| 38 | Multidrug‐resistant Trichophyton mentagrophytes genotype VIII in an Iranian family with generalized dermatophytosis: report of four cases and review of literature | 1.2 | 84 | Citations (PDF) |
| 39 | Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature | 2.1 | 7 | Citations (PDF) |
| 40 | The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis | 2.1 | 181 | Citations (PDF) |
| 41 | Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis | 2.2 | 31 | Citations (PDF) |
| 42 | Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran | 2.1 | 21 | Citations (PDF) |
| 43 | In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes | 2.1 | 39 | Citations (PDF) |
| 44 | Fatal necrotising cutaneous mucormycosis due to novel Saksenaea species: a case study | 0.9 | 7 | Citations (PDF) |
| 45 | MALDI‐TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples | 2.1 | 13 | Citations (PDF) |
| 46 | Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States | 2.5 | 72 | Citations (PDF) |
| 47 | MixInYeast: A Multicenter Study on Mixed Yeast Infections | 2.4 | 23 | Citations (PDF) |
| 48 | A Chronic Autochthonous Fifth Clade Case of Candida auris Otomycosis in Iran | 2.2 | 34 | Citations (PDF) |
| 49 | In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates | 2.0 | 3 | Citations (PDF) |
| 50 | Interactions between immune response to fungal infection and microRNAs: The pioneer tuners | 2.1 | 18 | Citations (PDF) |
| 51 | A systematic review of
Toxoplasma gondii
genotypes and feline: Geographical distribution trends | 1.2 | 39 | Citations (PDF) |
| 52 | Clonal Expansion of Environmental Triazole Resistant Aspergillus fumigatus in Iran | 2.4 | 20 | Citations (PDF) |
| 53 | Potent in vitro activity of curcumin and quercetin co-encapsulated in nanovesicles without hyaluronan against Aspergillus and Candida isolates | 1.5 | 43 | Citations (PDF) |
| 54 | Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ—Global Registry for Emerging Fungal Infections | 2.5 | 29 | Citations (PDF) |
| 55 | The urgent need for integrated science to fight COVID-19 pandemic and beyond | 4.8 | 144 | Citations (PDF) |
| 56 | Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates | 2.2 | 9 | Citations (PDF) |
| 57 | First azole‐resistant Aspergillus fumigatus isolates with the environmental TR46/Y121F/T289A mutation in Iran | 2.1 | 37 | Citations (PDF) |
| 58 | Epidemiological features of nosocomial candidaemia in neonates, infants and children: A multicentre study in Iran | 2.1 | 43 | Citations (PDF) |
| 59 | Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran | 2.2 | 33 | Citations (PDF) |
| 60 | Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex | 1.3 | 20 | Citations (PDF) |
| 61 | 1282. Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates <i>In vitro</i> Activity Against Members of the <i>Fusarium oxysporum</i> and <i>Fusarium solani</i> Species Complexes | 0.7 | 1 | Citations (PDF) |
| 62 | In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species | 2.2 | 30 | Citations (PDF) |
| 63 | In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis | 2.1 | 31 | Citations (PDF) |
| 64 | Potential Fifth Clade ofCandida auris,Iran, 2018 | 2.7 | 368 | Citations (PDF) |
| 65 | Antifungal Resistance Testing and Implications for Management | 2.4 | 16 | Citations (PDF) |
| 66 | Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium | 9.5 | 1,611 | Citations (PDF) |
| 67 | Unequivocal identification of an underestimated opportunistic yeast species, Cyberlindnera fabianii, and its close relatives using a dual-function PCR and literature review of published cases | 1.9 | 19 | Citations (PDF) |
| 68 | Novel Point Mutations in
cyp51A
and
cyp51B
Genes Associated with Itraconazole and Posaconazole Resistance in
Aspergillus clavatus
Isolates | 1.0 | 25 | Citations (PDF) |
| 69 | Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients | 2.1 | 16 | Citations (PDF) |
| 70 | Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries | 2.8 | 39 | Citations (PDF) |
| 71 | A simple and low cost tetra-primer ARMS-PCR method for detection triazole-resistant Aspergillus fumigatus | 1.9 | 11 | Citations (PDF) |
| 72 | New potent antifungal triazole alcohols containing N-benzylpiperazine carbodithioate moiety: Synthesis, in vitro evaluation and in silico study | 3.4 | 34 | Citations (PDF) |
| 73 | In vitro activity of nine antifungal agents against a global collection of Hortaea werneckii isolates, the agent of tinea nigra | 2.4 | 14 | Citations (PDF) |
| 74 | Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 45.2 | 5,043 | Citations (PDF) |
| 75 | Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 12.1 | 564 | Citations (PDF) |
| 76 | Candida auris otomycosis in Iran and review of recent literature | 2.1 | 99 | Citations (PDF) |
| 77 | An unusual case of gastrointestinal basidiobolomycosis mimicking colon cancer; literature and review | 1.5 | 29 | Citations (PDF) |
| 78 | Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017 | 15.9 | 518 | Citations (PDF) |
| 79 | Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 12.1 | 1,786 | Citations (PDF) |
| 80 | Epidemiology of Aspergillus species causing keratitis in Mexico | 2.1 | 32 | Citations (PDF) |
| 81 | YEAST PANEL multiplex PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries | 1.0 | 53 | Citations (PDF) |
| 82 | Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model | 2.1 | 124 | Citations (PDF) |
| 83 | Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned? | 1.5 | 36 | Citations (PDF) |
| 84 | Discovery of Benzylthio Analogs of Fluconazole as Potent Antifungal Agents | 1.8 | 21 | Citations (PDF) |
| 85 | Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015 | 45.2 | 157 | Citations (PDF) |
| 86 | Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40 | 45.2 | 218 | Citations (PDF) |
| 87 | Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry | 1.7 | 100 | Citations (PDF) |
| 88 | Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients | 2.4 | 10 | Citations (PDF) |
| 89 | In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions | 1.0 | 8 | Citations (PDF) |
| 90 | Use of cell surface protein typing for genotyping of azole‐resistant and ‐susceptible Aspergillus fumigatus isolates in Iran | 2.1 | 9 | Citations (PDF) |
| 91 | Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review | 2.1 | 23 | Citations (PDF) |
| 92 | In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex | 2.1 | 31 | Citations (PDF) |
| 93 | Evaluation of PCR-reverse line blot hybridization assay for simultaneous identification of medically important saprophytic fungi | 1.5 | 0 | Citations (PDF) |
| 94 | Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 45.2 | 930 | Citations (PDF) |
| 95 | Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 45.2 | 6,866 | Citations (PDF) |
| 96 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 45.2 | 4,386 | Citations (PDF) |
| 97 | Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 45.2 | 408 | Citations (PDF) |
| 98 | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 45.2 | 11,988 | Citations (PDF) |
| 99 | Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 | 45.2 | 448 | Citations (PDF) |
| 100 | Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 45.2 | 2,839 | Citations (PDF) |
| 101 | Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study | 9.5 | 241 | Citations (PDF) |
| 102 | Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 12.1 | 321 | Citations (PDF) |
| 103 | Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles | 2.4 | 44 | Citations (PDF) |
| 104 | Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism | 1.5 | 21 | Citations (PDF) |
| 105 | Frequency and Geographic Distribution of CARD9 Mutations in Patients With Severe Fungal Infections | 2.9 | 95 | Citations (PDF) |
| 106 | Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 | 45.2 | 881 | Citations (PDF) |
| 107 | Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? | 2.9 | 82 | Citations (PDF) |
| 108 | Low-Cost Tetraplex PCR for the Global Spreading Multi-Drug Resistant Fungus, Candida auris and Its Phylogenetic Relatives | 2.9 | 33 | Citations (PDF) |
| 109 | Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 45.2 | 2,974 | Citations (PDF) |
| 110 | Severe Disseminated Phaeohyphomycosis in a Patient with Inherited CARD9 Deficiency | 0.3 | 8 | Citations (PDF) |
| 111 | Consistent high prevalence of Exophiala dermatitidis, a neurotropic opportunist, on railway sleepers | 1.5 | 20 | Citations (PDF) |
| 112 | Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature | 1.5 | 26 | Citations (PDF) |
| 113 | A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study | 3.4 | 52 | Citations (PDF) |
| 114 | Coexistence of aspergilloma and pulmonary hydatid cyst in an immunocompetent individual | 1.5 | 7 | Citations (PDF) |
| 115 | Epidemiological and mycological characteristics of candidemia in Iran: A systematic review and meta-analysis | 1.5 | 71 | Citations (PDF) |
| 116 | In Vitro
Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives | 2.4 | 25 | Citations (PDF) |
| 117 | In Vitro
Interactions of Echinocandins with Triazoles against Multidrug-Resistant
Candida auris | 2.4 | 98 | Citations (PDF) |
| 118 | Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the
Cryptococcus
Genus | 2.2 | 145 | Citations (PDF) |
| 119 | In Vitro
Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species | 2.4 | 23 | Citations (PDF) |
| 120 | Whole Genome-Based Amplified Fragment Length Polymorphism Analysis Reveals Genetic Diversity in Candida africana | 2.9 | 19 | Citations (PDF) |
| 121 | Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates | 1.7 | 48 | Citations (PDF) |
| 122 | Genotyping of clinical and environmental Aspergillus flavus isolates from Iran using microsatellites | 2.1 | 18 | Citations (PDF) |
| 123 | In vitroactivity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates: Table 1. | 1.9 | 77 | Citations (PDF) |
| 124 | Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling | 2.0 | 18 | Citations (PDF) |
| 125 | Mucormycosis in Iran: a systematic review | 2.1 | 99 | Citations (PDF) |
| 126 | In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen | 1.5 | 22 | Citations (PDF) |
| 127 | Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata | 2.2 | 20 | Citations (PDF) |
| 128 | High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue? | 1.3 | 73 | Citations (PDF) |
| 129 | Disseminated Nocardiosis in an Immunocompetent Individual Infected with Nocardia brasiliensis, an Opportunistic Agent | 0.3 | 1 | Citations (PDF) |
| 130 | cyp51A gene silencing using RNA interference in azole‐resistant Aspergillus fumigatus | 2.1 | 17 | Citations (PDF) |
| 131 | Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature | 2.1 | 18 | Citations (PDF) |
| 132 | Global Spread of Human Chromoblastomycosis Is Driven by Recombinant Cladophialophora carrionii and Predominantly Clonal Fonsecaea Species | 1.9 | 26 | Citations (PDF) |
| 133 | First Autochthonous Coinfected Anthrax in an Immunocompetent Patient | 0.6 | 1 | Citations (PDF) |
| 134 | First fatal cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran, based on ITS rDNA | 1.5 | 17 | Citations (PDF) |
| 135 | Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents | 2.2 | 46 | Citations (PDF) |
| 136 | Multilocus sequence typing of Candida albicans isolates from a burn intensive care unit in Iran | 1.3 | 32 | Citations (PDF) |
| 137 | Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis | 2.2 | 48 | Citations (PDF) |
| 138 | In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs | 2.1 | 70 | Citations (PDF) |
| 139 | In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex | 2.2 | 39 | Citations (PDF) |
| 140 | Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review | 2.2 | 16 | Citations (PDF) |
| 141 | Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran | 2.2 | 70 | Citations (PDF) |
| 142 | Imidazolylchromanones containing non-benzylic oxime ethers: Synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii | 4.5 | 31 | Citations (PDF) |
| 143 | A reappraisal of orders and families within the subclass Chaetothyriomycetidae (Eurotiomycetes, Ascomycota) | 1.1 | 67 | Citations (PDF) |
| 144 | Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity | 2.0 | 34 | Citations (PDF) |
| 145 | Use of Rolling Circle Amplification to Rapidly Identify Species of Cladophialophora Potentially Causing Human Infection | 2.2 | 20 | Citations (PDF) |
| 146 | Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba | 2.2 | 22 | Citations (PDF) |
| 147 | Veronaea botryosa: Molecular Identification with Amplified Fragment Length Polymorphism (AFLP) and In vitro Antifungal Susceptibility | 2.2 | 24 | Citations (PDF) |
| 148 | Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser | 1.3 | 41 | Citations (PDF) |
| 149 | Severe Disseminated Phaeohyphomycosis in an Immunocompetent Patient Caused by Veronaea botryosa | 2.2 | 46 | Citations (PDF) |
| 150 | Molecular characterisation and pathogenicity of
Phaeoacremonium
spp. associated with esca disease of grapevine in Northern Iran | 0.8 | 23 | Citations (PDF) |
| 151 | An unusual case of eumycetoma caused by Exophiala jeanselmei after a sea urchin injury | 2.1 | 13 | Citations (PDF) |
| 152 | Environmental study of azole‐resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran | 2.1 | 104 | Citations (PDF) |
| 153 | First case of disseminated phaeohyphomycosis in an immunocompetent individual due to Alternaria malorum | 1.9 | 29 | Citations (PDF) |
| 154 | Cladophialophora abundans, a novel species of Chaetothyriales isolated from the natural environment | 1.1 | 26 | Citations (PDF) |
| 155 | Multiple subcutaneous cysts due toExophiala spiniferain an immunocompetent patient | 1.9 | 24 | Citations (PDF) |
| 156 | Epidemiology and molecular characterization of Cryptococcus neoformans isolated from pigeon excreta in Mazandaran province, northern Iran | 1.5 | 14 | Citations (PDF) |
| 157 | Fatal Cerebral Phaeohyphomycosis in an Immunocompetent Individual Due to Thielavia subthermophila | 2.5 | 16 | Citations (PDF) |
| 158 | Cladophialophora psammophila, a novel species of Chaetothyriales with a potential use in the bioremediation of volatile aromatic hydrocarbons | 1.9 | 77 | Citations (PDF) |
| 159 | Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic | 1.9 | 84 | Citations (PDF) |
| 160 | Waterborne Exophiala species causing disease in cold-blooded animals | 3.9 | 215 | Citations (PDF) |
| 161 | Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist | 1.9 | 46 | Citations (PDF) |
| 162 | Melanization of a Meristematic Mutant of Fonsecaea monophora Increases Tolerance to Stress Factors While no Effects on Antifungal Susceptibility | 2.2 | 26 | Citations (PDF) |
| 163 | In Vitro
Activities of Eight Antifungal Drugs against 55 Clinical Isolates of
Fonsecaea
spp | 2.4 | 69 | Citations (PDF) |
| 164 | In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection | 2.1 | 27 | Citations (PDF) |
| 165 | First Autochthonous Case of
Rhinocladiella mackenziei
Cerebral Abscess Outside the Middle East | 2.5 | 38 | Citations (PDF) |
| 166 | The clinical spectrum ofExophiala jeanselmei, with a case report andin vitroantifungal susceptibility of the species | 1.9 | 50 | Citations (PDF) |
| 167 | Use of Amplified Fragment Length Polymorphism To Identify 42
Cladophialophora
Strains Related to Cerebral Phaeohyphomycosis with In Vitro Antifungal Susceptibility | 2.5 | 62 | Citations (PDF) |
| 168 | Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis | 1.9 | 62 | Citations (PDF) |
| 169 | Subcutaneous phaeohyphomycotic cyst caused byPyrenochaeta romeroi | 1.9 | 41 | Citations (PDF) |
| 170 | Successful treatment of chromoblastomycosis of 36 years duration caused byFonsecaea monophora | 1.9 | 37 | Citations (PDF) |
| 171 | Cladophialophorasaturnicasp. nov., a new opportunistic species ofChaetothyrialesrevealed using molecular data | 1.9 | 64 | Citations (PDF) |
| 172 | In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species | 2.1 | 26 | Citations (PDF) |
| 173 | Genetic diversity and species delimitation in the opportunistic genusFonsecaea | 1.9 | 84 | Citations (PDF) |
| 174 | Biodiversity of the genus Cladophialophora | 4.1 | 203 | Citations (PDF) |
| 175 | Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico | 4.1 | 89 | Citations (PDF) |
| 176 | Seroepidemiological Study for Toxocariasis among Children in Zanjan-Northwest of Iran | 0.4 | 28 | Citations (PDF) |
| 177 | Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species | 4.1 | 127 | Citations (PDF) |
| 178 | Fungal Contamination in Indoor Swimming Pools in Zanjan-Iran 2005 | 0.4 | 5 | Citations (PDF) |
| 179 | Ten-Year Experience on 601 Patients with Mucormycosis at Eight Tertiary Care Centers in Iran | 2.2 | 1 | Citations (PDF) |
| 180 | Innovative green niosomal piperlongumine as a novel topical treatment for dermatophytosis in guinea pigs model | 2.7 | 1 | Citations (PDF) |
| 181 | In vitro activity of eight antifungal drugs against clinical and hospital isolates of Candida parapsilosis complex; a multicenter study, 2023–2024 | 1.7 | 1 | Citations (PDF) |
| 182 | Candidozyma auris and the Perfect Storm of Fungal Pathogenicity: Adaptation, Persistence, and Resistance | 2.4 | 0 | Citations (PDF) |
